Hokuyaku Takeyama Holdings, Inc operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hokuyaku Takeyama Holdings, Inc with three other
drug stores in Asia:
Vital KSK Holdings Incorporation
sales of 581.08 billion Japanese Yen [US$5.20 billion]
Immuno-Biological Laboratories Company Limited
(741.53 million Japanese Yen [US$6.64 million]
Toho Holdings Company Limited
(1.23 trillion Japanese Yen [US$11.02 billion]
During the year ended March of 2017, sales at
Hokuyaku Takeyama Holdings, Inc were ¥228.71 billion (US$2.05 billion).
a very small
increase of 1.6%
versus 2016, when the company's sales were ¥225.15 billion.